Geode Capital Management
SIOX

Geode Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Geode Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-432,270
Closed -$188K – 4861
2022
Q4 		$188K Sell
432,270
-1,116
-0.3% -$362 ﹤0.01% 4136
2022
Q3 		$121K Hold
433,386
– – ﹤0.01% 4484
2022
Q2 		$156K Buy
433,386
+2,178
+0.5% +$902 ﹤0.01% 4400
2022
Q1 		$288K Hold
431,208
– – ﹤0.01% 4198
2021
Q4 		$556K Buy
431,208
+37,404
+9% +$66.4K ﹤0.01% 3990
2021
Q3 		$854K Sell
393,804
-14,283
-3% -$31.1K ﹤0.01% 3765
2021
Q2 		$1.11M Buy
408,087
+360,218
+753% +$896K ﹤0.01% 3535
2021
Q1 		$124K Hold
47,869
– – ﹤0.01% 4255
2020
Q4 		$133K Buy
47,869
+24,811
+108% +$72.2K ﹤0.01% 4005
2020
Q3 		$106K Sell
23,058
-35,255
-60% -$116K ﹤0.01% 3889
2020
Q2 		$164K Buy
58,313
+14,088
+32% +$45.2K ﹤0.01% 3713
2020
Q1 		$107K Buy
44,225
+8,378
+23% +$30.2K ﹤0.01% 3744
2019
Q4 		$183K Buy
35,847
+15,732
+78% +$87.2K ﹤0.01% 3825
2019
Q3 		$129K Hold
20,115
– – ﹤0.01% 3891
2019
Q2 		$125K Sell
20,115
-1,854
-8% -$14.1K ﹤0.01% 3908
2019
Q1 		$233K Buy
21,969
+10,083
+85% +$100K ﹤0.01% 3694
2018
Q4 		$94K Buy
11,886
+6,437
+118% +$92.8K ﹤0.01% 3873
2018
Q3 		$105K Sell
5,449
-15,910
-74% -$290K ﹤0.01% 3914
2018
Q2 		$386K Buy
21,359
+7,502
+54% +$111K ﹤0.01% 3523
2018
Q1 		$147K Buy
13,857
+904
+7% +$14.5K ﹤0.01% 3765
2017
Q4 		$546K Sell
12,953
-6,576
-34% -$295K ﹤0.01% 3325
2017
Q3 		$1.07M Buy
19,529
+12,746
+188% +$2.15M ﹤0.01% 3092
2017
Q2 		$1.26M Buy
6,783
+1,621
+31% +$284K ﹤0.01% 2998
2017
Q1 		$616K Buy
5,162
+788
+18% +$82.6K ﹤0.01% 3230
2016
Q4 		$434K Buy
4,374
+516
+13% +$54.3K ﹤0.01% 3318
2016
Q3 		$432K Buy
3,858
+292
+8% +$35.1K ﹤0.01% 3310
2016
Q2 		$366K Buy
3,566
+1,716
+93% +$172K ﹤0.01% 3350
2016
Q1 		$169K Sell
1,850
-303
-14% -$32.3K ﹤0.01% 3685
2015
Q4 		$310K Buy
2,153
+471
+28% +$61.3K ﹤0.01% 3496
2015
Q3 		$173K Buy
+1,682
New +$197K ﹤0.01% 3731

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Geode Capital Management's SIOX Position: Q1 2023 in Review

Geode Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 432,270 shares — an estimated $188K sold.

Geode Capital Management first reported a position in SIOX in Q3 2015 and held it in 30 quarters. The position peaked at $1.26M in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Geode Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 432,270 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $188K.
  • Geode Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 30 quarters.
  • Geode Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $1.26M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.